• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DT-黄递酶可保护细胞免受吲哚醌EO9的缺氧细胞毒性作用。

DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.

作者信息

Plumb J A, Gerritsen M, Workman P

机构信息

CRC Department of Medical Oncology, University of Glasgow, Bearsden, UK.

出版信息

Br J Cancer. 1994 Dec;70(6):1136-43. doi: 10.1038/bjc.1994.461.

DOI:10.1038/bjc.1994.461
PMID:7526885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2033714/
Abstract

Aerobic sensitivity to indoloquinone EO9 has been shown to correlate with cellular levels of the two-electron reducing enzyme DT-diaphorase. However, little is known about the relative roles of one- and two-electron reducing enzymes in the hypoxic cytotoxicity of EO9. We have characterised a panel of 23 human tumour cell lines for both bioreductive enzyme activities and aerobic sensitivity to EO9. Eight cell lines were then selected for a comparison of aerobic and hypoxic sensitivities. Activities of DT-diaphorase showed a wide range (> 10,000-fold), while activities of the one-electron reducing cytochrome b5 and cytochrome P450 reductases were generally lower and showed only a 15- and 25-fold range respectively. The aerobic cytotoxicity of EO9 was clearly related to the cellular levels of DT-diaphorase (r = 0.87), with higher levels giving increased sensitivity, but not to the levels of one-electron reducing enzymes. In contrast, there was no relationship between sensitivity to BCNU, cisplatin or the bioreductive agent SR 4233 (tirapazamine) and activities of any of these reducing enzymes. Under hypoxic conditions sensitivity to EO9 was markedly increased in cell lines with low levels of DT-diaphorase activity, while cell lines with high levels show only a small increase in sensitivity. This is reflected by a clear correlation (r = 0.98) between cellular DT-diaphorase activity and the ratio of aerobic to hypoxic sensitivity to EO9. However, we have now for the first time demonstrated an inverse correlation (r = 0.93) between the cellular activity of DT-diaphorase and hypoxic sensitivity to EO9, that is sensitivity decreases with increasing DT-diaphorase activity. Moreover, this correlation was lost when cells were exposed to drug in the presence of dicoumarol, supporting an involvement of DT-diaphorase in this relationship. These observations question the previously straightforward role for DT-diaphorase in the metabolic activation of EO9. Whereas DT-diaphorase is associated with increased toxicity in air, it appears to reduce the cytotoxicity of EO9 in hypoxic conditions. This suggests either that the one-electron reduction product of EO9 metabolism, the semiquinone, is more toxic than the two-electron reduction product, the hydroquinone, or that the hydroquinone is not cytotoxic and aerobic toxicity is due to the transient appearance of the semiquinone upon back oxidation of the hydroquinone.

摘要

已证明对吲哚醌EO9的需氧敏感性与双电子还原酶DT-黄递酶的细胞水平相关。然而,关于单电子和双电子还原酶在EO9缺氧细胞毒性中的相对作用,人们了解甚少。我们已对一组23种人类肿瘤细胞系的生物还原酶活性和对EO9的需氧敏感性进行了表征。然后选择了8种细胞系来比较需氧和缺氧敏感性。DT-黄递酶的活性范围很广(>10,000倍),而单电子还原细胞色素b5和细胞色素P450还原酶的活性通常较低,分别仅显示15倍和25倍的范围。EO9的需氧细胞毒性显然与DT-黄递酶的细胞水平相关(r = 0.87),水平越高敏感性越高,但与单电子还原酶的水平无关。相比之下,对卡莫司汀、顺铂或生物还原剂SR 4233(替拉扎明)的敏感性与这些还原酶中任何一种的活性之间均无关系。在缺氧条件下,DT-黄递酶活性低的细胞系对EO9的敏感性显著增加,而DT-黄递酶活性高的细胞系敏感性仅略有增加。这通过细胞DT-黄递酶活性与对EO9的需氧敏感性与缺氧敏感性之比之间的明显相关性(r = 0.98)得以体现。然而,我们现在首次证明了DT-黄递酶的细胞活性与对EO9的缺氧敏感性之间呈负相关(r = 0.93),即敏感性随DT-黄递酶活性的增加而降低。此外,当细胞在双香豆素存在下接触药物时,这种相关性消失了,这支持了DT-黄递酶参与这种关系。这些观察结果对DT-黄递酶在EO9代谢活化中先前直接的作用提出了质疑。虽然DT-黄递酶与空气中毒性增加有关,但它似乎在缺氧条件下降低了EO9的细胞毒性。这表明要么EO9代谢的单电子还原产物半醌比双电子还原产物对苯二酚毒性更大,要么对苯二酚没有细胞毒性,需氧毒性是由于对苯二酚回氧化时半醌的短暂出现所致。

相似文献

1
DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.DT-黄递酶可保护细胞免受吲哚醌EO9的缺氧细胞毒性作用。
Br J Cancer. 1994 Dec;70(6):1136-43. doi: 10.1038/bjc.1994.461.
2
Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines.人肺肿瘤细胞系中DT-黄递酶和缺氧在EO9生物活化中的相对重要性。
Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):295-9. doi: 10.1016/0360-3016(94)90278-x.
3
Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.国立癌症研究所肿瘤细胞系面板中的还原酶表达:与对丝裂霉素C和EO9敏感性的相关性
J Natl Cancer Inst. 1996 Mar 6;88(5):259-69. doi: 10.1093/jnci/88.5.259.
4
Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity.在一种缺乏DT-黄递酶活性的人结肠肿瘤细胞系中,对吲哚醌EO9和丝裂霉素C表现出异常显著的低氧致敏作用。
Int J Cancer. 1994 Jan 2;56(1):134-9. doi: 10.1002/ijc.2910560124.
5
The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.功能基团对DT-黄递酶还原和激活醌类生物还原剂的影响。
Cancer Chemother Pharmacol. 2002 Feb;49(2):101-10. doi: 10.1007/s00280-001-0395-1. Epub 2001 Nov 24.
6
Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase.吲哚醌EO9:经DT-黄递酶或黄嘌呤氧化酶还原后形成DNA链间交联。
Br J Cancer. 1995 Apr;71(4):836-9. doi: 10.1038/bjc.1995.161.
7
The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.NAD(P)H:醌还原酶(EC 1.6.99.2,DT-黄递酶)在新型吲哚醌抗肿瘤药物EO9的还原性生物活化中的作用
Cancer Commun. 1991 Jul;3(7):199-206. doi: 10.3727/095535491820873164.
8
Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development.5,6-二甲基呫吨酮-4-乙酸(DMXAA)和黄酮-8-乙酸(FAA)对DT-黄递酶(NAD(P)H:醌氧化还原酶,EC 1.6.99.2)的抑制作用:对生物还原药物开发的启示。
Biochem Pharmacol. 1999 Jul 15;58(2):303-10. doi: 10.1016/s0006-2952(99)00092-1.
9
Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species.烟酰胺腺嘌呤二核苷酸磷酸(NADPH):细胞色素P450还原酶参与吲哚醌EO9激活形成自由基和DNA损伤性物质的过程。
Biochem Pharmacol. 2001 Aug 15;62(4):461-8. doi: 10.1016/s0006-2952(01)00674-8.
10
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.DT-黄递酶(EC 1.6.99.2)在生物还原抗肿瘤药物EO9的DNA交联及序列选择性中的作用。
Br J Cancer. 1997;76(12):1596-603. doi: 10.1038/bjc.1997.603.

引用本文的文献

1
Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging.人类 NQO1 作为抗癌治疗和肿瘤成像的选择性靶标。
Cells. 2024 Jul 29;13(15):1272. doi: 10.3390/cells13151272.
2
Aerobic Cytotoxicity of Aromatic Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1).芳香族氧化物的需氧细胞毒性:NAD(P)H:醌氧化还原酶(NQO1)的作用。
Int J Mol Sci. 2020 Nov 19;21(22):8754. doi: 10.3390/ijms21228754.
3
Targeting hypoxia in the leukemia microenvironment.靶向白血病微环境中的缺氧状态。
Int J Hematol Oncol. 2013 Aug 1;2(4):279-288. doi: 10.2217/IJH.13.32.
4
Impact of tumor blood flow modulation on tumor sensitivity to the bioreductive drug banoxantrone.肿瘤血流调节对生物还原药物拜诺单抗敏感性的影响。
J Pharmacol Exp Ther. 2013 Feb;344(2):368-77. doi: 10.1124/jpet.112.200089. Epub 2012 Nov 28.
5
EO9 (Apaziquone): from the clinic to the laboratory and back again.EO9(阿帕齐喹酮):从临床到实验室,再回到临床。
Br J Pharmacol. 2013 Jan;168(1):11-8. doi: 10.1111/j.1476-5381.2012.01996.x.
6
Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.新型lavendamycin 抗肿瘤剂的合成、代谢及体外细胞毒性研究。
Bioorg Med Chem. 2010 Mar 1;18(5):1899-909. doi: 10.1016/j.bmc.2010.01.037. Epub 2010 Jan 25.
7
Pharmacological approach towards the development of indolequinone bioreductive drugs based on the clinically inactive agent EO9.基于临床无活性药物EO9开发吲哚醌生物还原药物的药理学方法。
Br J Pharmacol. 2002 Nov;137(5):701-9. doi: 10.1038/sj.bjp.0704916.
8
Nitroxides as antioxidants: Tempol protects against EO9 cytotoxicity.氮氧化物作为抗氧化剂:Tempol可抵御EO9的细胞毒性。
Mol Cell Biochem. 2002 May-Jun;234-235(1-2):327-33.
9
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.DT-黄递酶(EC 1.6.99.2)在生物还原抗肿瘤药物EO9的DNA交联及序列选择性中的作用。
Br J Cancer. 1997;76(12):1596-603. doi: 10.1038/bjc.1997.603.
10
Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.人NADPH:细胞色素c(P450)还原酶的过表达赋予对替拉扎明(SR 4233)和RSU 1069两者的敏感性增强。
Br J Cancer. 1997;76(10):1338-47. doi: 10.1038/bjc.1997.558.

本文引用的文献

1
EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models.EO9:一种新型的生物还原烷基化吲哚醌,在临床前模型中具有优先的实体瘤活性且无骨髓毒性。
Eur J Cancer. 1993;29A(6):897-906. doi: 10.1016/s0959-8049(05)80434-4.
2
The experimental development of bioreductive drugs and their role in cancer therapy.生物还原药物的实验进展及其在癌症治疗中的作用。
Cancer Metastasis Rev. 1993 Jun;12(2):73-82. doi: 10.1007/BF00689802.
3
Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity.在一种缺乏DT-黄递酶活性的人结肠肿瘤细胞系中,对吲哚醌EO9和丝裂霉素C表现出异常显著的低氧致敏作用。
Int J Cancer. 1994 Jan 2;56(1):134-9. doi: 10.1002/ijc.2910560124.
4
Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.丝裂霉素C与EMT6小鼠乳腺肿瘤细胞中DNA的加合物:缺氧和双香豆素对加合物模式的影响
Cancer Res. 1993 Nov 1;53(21):5127-34.
5
Chemosensitivity to the indoloquinone EO9 is correlated with DT-diaphorase activity and its gene expression.对吲哚醌EO9的化学敏感性与DT-黄递酶活性及其基因表达相关。
Biochem Pharmacol. 1994 Apr 20;47(8):1325-32. doi: 10.1016/0006-2952(94)90330-1.
6
Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase.由NADPH-细胞色素P-450还原酶和黄嘌呤氧化酶催化的丝裂霉素C及丝裂霉素C代谢物的还原活化作用。
J Biol Chem. 1984 Jan 25;259(2):959-66.
7
Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductase.在存在NADPH-细胞色素P-450还原酶的情况下,抗癌醌类药物卡巴醌、丝裂霉素C、阿克拉霉素A和阿霉素生成羟自由基。
Biochem Pharmacol. 1982 Nov 15;31(22):3651-6. doi: 10.1016/0006-2952(82)90590-1.
8
One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase).生物化学体系中的单电子转移反应。V. NADH脱氢酶和NAD(P)H脱氢酶(DT-黄递酶)还原醌的机制差异
Biochim Biophys Acta. 1970 Sep 1;216(2):282-94. doi: 10.1016/0005-2728(70)90220-3.
9
Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver.小鼠肝脏中单功能和双功能抗癌酶诱导剂的调控机制
Cancer Res. 1988 Sep 1;48(17):4776-82.
10
Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.鳞状细胞癌转移灶中的氧分布及其与放射治疗结果的关系。
Int J Radiat Oncol Biol Phys. 1988 May;14(5):831-8. doi: 10.1016/0360-3016(88)90002-8.